New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabivarin

Roger Guy Pertwee (Inventor), Geoffrey W Guy (Inventor), Brian Whittle (Inventor)

Research output: Patent

Abstract

The present invention relates to a novel pharmaceutical formulation comprising a ratioed mix of: (i) one or more compounds that acts as an inverse agonist of the CB1 and/or CB2 receptor; and (ii) one or more compounds that acts as a neutral antagonist of the CB1 and/or CB2 receptor. Preferably both the inverse agonist of the CB1 and/or CB2 receptor and the neutral antagonist of the CB1 and/or CB2 receptor are cannabinoids. Preferably the cannabinoids are tetrahydrocannabidivarin (THCV) and cannabidiol (CBD).
Original languageEnglish
Patent numberWO2009007697
IPCA61K31/05; A61K31/352; A61K36/185; A61P19/08;
Publication statusPublished - 15 Jan 2009

    Fingerprint

Cite this

Pertwee, R. G., Guy, G. W., & Whittle, B. (2009). IPC No. A61K31/05; A61K31/352; A61K36/185; A61P19/08;. New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabivarin. (Patent No. WO2009007697).